FT TECH
Featured
Crispr gene editing technology could transform medicine
Crispr gene editing technology could transform medicine, but questions such as the long-term effects on patients, how much it will cost, and who will have access to it, still need answers.
More from the FT Tech channel
The EU’s plan to overhaul connectivity patent rules could prove counter-productive
There are fears that EU plans to change the way patent holders are paid for their intellectual property may actually end up hindering innovation.
The creator economy is changing, but who’s making money, and can it thrive?
The number of online creators active today is staggering, but wealth tends to be concentrated among the very few, and the industry has received mixed financial signals recently. So, what does the future hold?
FT Guides
Digital financial services
FT journalists explain applications of new developments in financial services
Read more on ft.comDiscover more content on the topics that inspire, engage and inform the world we live in today at the FT Channels hub.
Discover more